Meaghan Bartlett
Manager, Evidence Synthesis
Expertise:
Meaghan is a project manager with over six years of experience in systematic literature reviews, indirect treatment comparisons and scientific communications.
In her time as part of the Value & Evidence team at EVERSANA, Meaghan has completed projects in a variety of disease areas including psoriasis, psoriatic arthritis, breast cancer, prostate cancer, multiple myeloma and hereditary angioedema. She is experienced in developing manuscripts and conference materials (e.g., abstracts and posters), and has been published in Future Oncology, Value in Health, and the Journal of Comparative Effectiveness Research. She also led the production of a whiteboard animation to support another EVERSANA publication.
Through her previous work experience Meaghan has collaborated with researchers and developed scientific communication materials for lay audiences.
Meaghan’s academic training includes a MSc in Health Technology Assessment from the University of Glasgow. In addition, she holds a BSc in Science Communications from Mount Saint Vincent University with a focus in Biology.
Articles by Meaghan Bartlett
Enhancing Quality of Life in Advanced Breast Cancer: The Role of Palbociclib
Advanced breast cancer often comes with significant physical symptoms, such as pain and fatigue, as well as side effects from treatments. The diagnosis and treatment of advanced breast cancer can lead to anxiety, depression and stress. Improving a patient’s quality of life can help manage these symptoms more effectively, making daily life more bearable. Focusing on quality of life in the face of a challenging diagnosis has become a primary goal of breast cancer therapy, particularly in the advanced setting, where outcomes are often poor. Palbociclib, a first-in-class cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, received approval from the United States (U.S.) Food and Drug Administration in 2015 for the treatment of […]